Understanding how different cell types affect disease through advanced data analysis.
Novel Systems Biology Methods for the Cell-type-specific Regulatory Networks Reconstruction from scRNA-seq Data
['FUNDING_R15'] · SAINT LOUIS UNIVERSITY · NIH-10798498
This study is looking at how different types of cells in complex diseases work by using advanced technology to understand their gene activity, with the hope of creating more personalized and effective treatments just for you.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SAINT LOUIS UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10798498 on ClinicalTrials.gov |
What this research studies
This research focuses on using modern single-cell RNA sequencing (scRNA-seq) technologies to analyze the diverse types of cells involved in complex diseases. By examining the gene expression of thousands of individual cells, the study aims to reconstruct specific regulatory networks that govern cell behavior. This approach seeks to overcome challenges such as missing data in scRNA-seq, which can hinder accurate analysis. Ultimately, the goal is to develop personalized treatments that are more effective for individual patients based on their unique cellular profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with complex diseases that exhibit cellular diversity and for whom current treatments are ineffective.
Not a fit: Patients with conditions that do not involve complex cellular interactions or those who do not respond to personalized medicine approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for complex diseases by targeting specific cell types.
How similar studies have performed: Other research has shown promise in using single-cell RNA sequencing for understanding cellular diversity, indicating that this approach could yield significant insights.
Where this research is happening
SAINT LOUIS, UNITED STATES
- SAINT LOUIS UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GONG, HAIJUN — SAINT LOUIS UNIVERSITY
- Study coordinator: GONG, HAIJUN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.